AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
76 hedge funds and large institutions have $101M invested in AVEO Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
11% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 19
Holders
76
Holding in Top 10
–
Calls
$7.28M
Puts
$5.28M
Top Buyers
| 1 | +$11M | |
| 2 | +$7.06M | |
| 3 | +$5.68M | |
| 4 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$2.2M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$1.83M |
Top Sellers
| 1 | -$8.23M | |
| 2 | -$705K | |
| 3 | -$631K | |
| 4 |
Millennium Management
New York
|
-$535K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$525K |